Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Spending Expected To Grow 5% In First Year of Expanded Health Coverage, CMS Predicts

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS projects the year-over-year growth in retail prescription drug spending to jump from a negative to flat growth in 2012 and 2013 to more than 5% in 2014 and nearly 7% in 2015, largely due to expanded health care coverage under the Affordable Care Act.

You may also be interested in...



ACA Countdown: Details Emerging On Exchanges, Medicaid Expansion

Open enrollment in state exchange plans kicks off Oct. 1 and expanded Medicaid eligibility Jan. 1, and many states offer a preliminary view of how coverage will play out under the Affordable Care Act in 2014.

Flat Drug Utilization Trend May Continue Into 2014 Despite ACA Expansion – Express Scripts

CEO George Paz cites the “teetering” economy and unemployment as reasons to expect utilization will stay flat and doesn’t anticipate the company will see a substantial sales bump from the Affordable Care Act next year.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS076262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel